Pharmaceuticals in Singapore
Pharmaceuticals in Singapore
SUMMARY
Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Singaporean pharmaceuticals market had total revenues of $940.6m in 2019, representing a compound annual growth rate (CAGR) of 2% between 2015 and 2019.
- The Singaporean healthcare is the best in the world in terms of both efficiency and health outcome results. Singapore has a record of providing a world-class business environment and skilled talent pool to companies.
- The Singapore government has invested aggressively in its biomedical industry over the last few years.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts
- What was the size of the Singapore pharmaceuticals market by value in 2019?
- What will be the size of the Singapore pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the Singapore pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Singapore's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What trends have impacted the market?
7.6. Are there any threats towards leading players?
8 COMPANY PROFILES
8.1. Novartis AG
8.2. Pfizer Inc.
8.3. Astellas Pharma Inc.
8.4. GlaxoSmithKline Plc
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What trends have impacted the market?
7.6. Are there any threats towards leading players?
8 COMPANY PROFILES
8.1. Novartis AG
8.2. Pfizer Inc.
8.3. Astellas Pharma Inc.
8.4. GlaxoSmithKline Plc
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Singapore pharmaceuticals market value: $ billion, 2015-19
Table 2: Singapore pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Singapore pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Singapore pharmaceuticals market share: % share, by value, 2019
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Annual Financial Ratios (Continued)
Table 8: Novartis AG: Key Employees
Table 9: Novartis AG: Key Employees Continued
Table 10: Pfizer Inc.: key facts
Table 11: Pfizer Inc.: Annual Financial Ratios
Table 12: Pfizer Inc.: Key Employees
Table 13: Pfizer Inc.: Key Employees Continued
Table 14: Astellas Pharma Inc.: key facts
Table 15: Astellas Pharma Inc.: Annual Financial Ratios
Table 16: Astellas Pharma Inc.: Key Employees
Table 17: Astellas Pharma Inc.: Key Employees Continued
Table 18: GlaxoSmithKline Plc: key facts
Table 19: GlaxoSmithKline Plc: Annual Financial Ratios
Table 20: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)
Table 21: GlaxoSmithKline Plc: Key Employees
Table 22: GlaxoSmithKline Plc: Key Employees Continued
Table 23: Singapore size of population (million), 2015-19
Table 24: Singapore gdp (constant 2005 prices, $ billion), 2015-19
Table 25: Singapore gdp (current prices, $ billion), 2015-19
Table 26: Singapore inflation, 2015-19
Table 27: Singapore consumer price index (absolute), 2015-19
Table 28: Singapore exchange rate, 2015-19
Table 1: Singapore pharmaceuticals market value: $ billion, 2015-19
Table 2: Singapore pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Singapore pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Singapore pharmaceuticals market share: % share, by value, 2019
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Annual Financial Ratios (Continued)
Table 8: Novartis AG: Key Employees
Table 9: Novartis AG: Key Employees Continued
Table 10: Pfizer Inc.: key facts
Table 11: Pfizer Inc.: Annual Financial Ratios
Table 12: Pfizer Inc.: Key Employees
Table 13: Pfizer Inc.: Key Employees Continued
Table 14: Astellas Pharma Inc.: key facts
Table 15: Astellas Pharma Inc.: Annual Financial Ratios
Table 16: Astellas Pharma Inc.: Key Employees
Table 17: Astellas Pharma Inc.: Key Employees Continued
Table 18: GlaxoSmithKline Plc: key facts
Table 19: GlaxoSmithKline Plc: Annual Financial Ratios
Table 20: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)
Table 21: GlaxoSmithKline Plc: Key Employees
Table 22: GlaxoSmithKline Plc: Key Employees Continued
Table 23: Singapore size of population (million), 2015-19
Table 24: Singapore gdp (constant 2005 prices, $ billion), 2015-19
Table 25: Singapore gdp (current prices, $ billion), 2015-19
Table 26: Singapore inflation, 2015-19
Table 27: Singapore consumer price index (absolute), 2015-19
Table 28: Singapore exchange rate, 2015-19
LIST OF FIGURES
Figure 1: Singapore pharmaceuticals market value: $ billion, 2015-19
Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Singapore pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Singapore, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Singapore, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Singapore, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2019
Figure 10: Singapore pharmaceuticals market share: % share, by value, 2019
Figure 1: Singapore pharmaceuticals market value: $ billion, 2015-19
Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Singapore pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Singapore, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Singapore, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Singapore, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2019
Figure 10: Singapore pharmaceuticals market share: % share, by value, 2019